Supporters and Exhibitors
The COGI Congress would like to thank the supporters. It is with the support of the industry that COGI can continue in its mission to promote research and education and to disseminate new knowledge
Click on the logo to find out more about the company!
Gold Supporters
 |
Silver Supporters
 |
Exhibitors
 |
|
|
Austrian-based Gonadosan Distribution GmbH is dedicated to the development and research of state-of-the-art nutraceuticals meeting the specific nutritional needs of men and women planning for pregnancy. The Fertilovit® range of supplements is based on the latest scientific data, tested in cooperation with big European ART centers and has been proven to support fertility treatment effectively. A variety of patent-protected preparations offer highly specific solutions for different male and female fertility patients, ranging from mature patients to patients with thyroid autoimmunity, endometriosis, PCOS, and idiopathic OAT.
For more information please visit www.fertilovit.com
For more information please visit www.fertilovit.com
IBSA is an international pharmaceutical company with headquarters in Lugano, Switzerland.
IBSA has developed an entirely new purification process in order to obtain a full range of highly purified, human gonadotrophins (hFSH, hMG and hCG). This patented process ensures both a high level of purity and the full respect of the natural glycosylation of these molecules.
Recently IBSA has marketed a novel ingenious system to deliver progesterone subcutaneously in an aqueous solution.
IBSA has managed to guarantee the highest quality of its products over the years due to the advantages of having a complete in-house manufacturing process in company-owned plants and thanks to a global quality system.
The company’s other franchises include osteoarthritis, pain-management, dermatology and thyroid diseases.
For more information please visit www.ibsagroup.com
IBSA has developed an entirely new purification process in order to obtain a full range of highly purified, human gonadotrophins (hFSH, hMG and hCG). This patented process ensures both a high level of purity and the full respect of the natural glycosylation of these molecules.
Recently IBSA has marketed a novel ingenious system to deliver progesterone subcutaneously in an aqueous solution.
IBSA has managed to guarantee the highest quality of its products over the years due to the advantages of having a complete in-house manufacturing process in company-owned plants and thanks to a global quality system.
The company’s other franchises include osteoarthritis, pain-management, dermatology and thyroid diseases.
For more information please visit www.ibsagroup.com
Gedeon Richter Plc., headquartered in Budapest, Hungary, is a major pharmaceutical company in Central Eastern Europe, with an expanding direct presence in Western Europe, China and Latin America. The product portfolio of Richter covers many important therapeutic areas, including Women’s Healthcare, Neuroscience and Cardiovascular medicine. Having the largest R&D unit in Central Eastern Europe and building upon its original focus in CNS disorders and its widely acknowledged steroid chemistry expertise, Richter has also become a significant player in the Women’s Healthcare field worldwide. Richter is also active in biosimilar product development.
For more information please visit www.richter.hu
For more information please visit www.richter.hu
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Headquartered in Saint-Prex, Switzerland, Ferring is a leader in reproductive medicine and women’s health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years and has a portfolio covering treatments from conception to birth. Founded in 1950, privately-owned Ferring now employs approximately 6,500 people worldwide, has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries.
For more information please visit www.ferring.com
For more information please visit www.ferring.com
Cryos International is here to help people on their path to parenthood. We are proud to provide specialized reproductive products, excellent customer care, and personal consultation – and we have done so for over 30 years. Our sperm come from all backgrounds and represents a large variety of ethnicities and phenotypes.
We have computerised systems that have been designed and worked on for over a decade, in order to ensure traceability and security. Furthermore, we are licensed according to the FDA and EU-Tissue Directive, setting the highest standards of quality and safety. For Cryos, it’s personal!
For more information about Cryos please visit dk.cryosinternational.com
We have computerised systems that have been designed and worked on for over a decade, in order to ensure traceability and security. Furthermore, we are licensed according to the FDA and EU-Tissue Directive, setting the highest standards of quality and safety. For Cryos, it’s personal!
For more information about Cryos please visit dk.cryosinternational.com
Fotona
With more than 50 years of experience, Fotona is a world-leading medical laser manufacturer recognized for its innovative, award-winning laser systems for applications in gynecology, surgery, aesthetics & dermatology and dentistry.
Fotona’s combined Er:YAG and Nd:YAG laser systems are proven to be less invasive and highly effective for clinical and aesthetic gynecology treatments. We are proud to be the first manufacturer to introduce SMOOTH® mode technology for a range of non-invasive laser vaginal treatments.
Our global distribution network spans across more than 90 countries, ensuring comprehensive support and service for Fotona laser users, including clinical training, workshops and hands-on demonstrations.
For more information about Fotona please visit www.fotona.com
With more than 50 years of experience, Fotona is a world-leading medical laser manufacturer recognized for its innovative, award-winning laser systems for applications in gynecology, surgery, aesthetics & dermatology and dentistry.
Fotona’s combined Er:YAG and Nd:YAG laser systems are proven to be less invasive and highly effective for clinical and aesthetic gynecology treatments. We are proud to be the first manufacturer to introduce SMOOTH® mode technology for a range of non-invasive laser vaginal treatments.
Our global distribution network spans across more than 90 countries, ensuring comprehensive support and service for Fotona laser users, including clinical training, workshops and hands-on demonstrations.
For more information about Fotona please visit www.fotona.com
CeGaT GmbH is a leading global provider of genetic diagnostics and mutation-related disease analyses. The company combines its next-generation sequencing (NGS) process and analysis pipelines with its medical expertise – dedicated to identifying the genetic cause of disease and supporting patient management.
Through NGS, it is possible to analyze all genes associated with a disease phenotype simultaneously – both fast and effectively. An interdisciplinary team of scientists and physicians evaluates the data and summarizes the findings in a comprehensive medical report. All services are performed in-house.
CeGaT, founded in 2009 and based in Tübingen, Germany, is accredited according to CAP, CLIA, and DIN EN ISO 15189:2014.
For more information about Cegat please visit www.cegat.de
Through NGS, it is possible to analyze all genes associated with a disease phenotype simultaneously – both fast and effectively. An interdisciplinary team of scientists and physicians evaluates the data and summarizes the findings in a comprehensive medical report. All services are performed in-house.
CeGaT, founded in 2009 and based in Tübingen, Germany, is accredited according to CAP, CLIA, and DIN EN ISO 15189:2014.
For more information about Cegat please visit www.cegat.de
KARL STORZ is a renowned manufacturer that is well established in all fields of endoscopy and can be considered as market leader in rigid endoscopy. The still family held company was founded in 1945 in Tuttlingen, Germany, and has grown to one with a worldwide presence and 8300 employees. KARL STORZ offers a range of both rigid and flexible endoscopes for a broad variety of applications. Today’s product range also includes fully integrated concepts for the OR and servicing.
For more information about Karl Storz please visit www.karlstorz.com
For more information about Karl Storz please visit www.karlstorz.com
Permanent International and European School in Perinatal, Neonatal and Reproductive Medicine.
Founded in Florence (Italy) in 2012, the School, inspired by the values of scientific culture, ethics and bioethics of life sciences, pursues the aim of promoting and enhancing the fundamental ideals of maternal infant medicine in its entire course: reproductive, periconceptional, maternal and child health periods. The School run courses of reproductive, perinatal and neonatal medicine and related disciplines, training programs, national and international conferences, congresses, debates, and any other event or action consistent with its objectives.
For more information about Preis School please visit www.preischool.com
Founded in Florence (Italy) in 2012, the School, inspired by the values of scientific culture, ethics and bioethics of life sciences, pursues the aim of promoting and enhancing the fundamental ideals of maternal infant medicine in its entire course: reproductive, periconceptional, maternal and child health periods. The School run courses of reproductive, perinatal and neonatal medicine and related disciplines, training programs, national and international conferences, congresses, debates, and any other event or action consistent with its objectives.
For more information about Preis School please visit www.preischool.com
Founded in 2009, Clovis Oncology is a commercial stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Clovis’ product development programs generally target specific subsets of cancer, and the Company seeks to simultaneously develop, with partners, for those indications that require them, diagnostic tools intended to direct a compound in development to the patients most likely to benefit from their use. Through these collaborations, Clovis has the flexibility to choose the most appropriate technology for each program, and the expertise to gain regulatory approvals and support global commercialization that will parallel Clovis’ regulatory and commercialization paths.
For more information about Clovis please visit www.clovisoncology.com
For more information about Clovis please visit www.clovisoncology.com
Pantarhei Bioscience (PRB) and Pantarhei Oncology (PRO) focus on innovative drug development in Woman’s Health (WH) and Endocrine Cancers.
PRB has developed a product pipeline based on its ability to identify, confirm and patent protect novel targets and medical uses of existing drugs, hormones, other endogenous human biologicals and combinations thereof. Pantarhei adheres to the highest scientific standards for preclinical and clinical drug development.
The current pipeline of Pantarhei includes (i) Androgen Restored Contraception (ARC), adding dehydroepiandrosterone (DHEA) to oral contraceptives, (ii) the fetal estrogen Estetrol (E4) for the (co)-treatment of breast and prostate cancer and (iii) the use of the Zona Pellucida 3 (ZP3) antigen and biomarker for immunotherapy of ZP3 expressing tumors such as ovarian and prostate cancer.
For more information please visit www.pantarheibio.com or www.pantarheioncology.nl
PRB has developed a product pipeline based on its ability to identify, confirm and patent protect novel targets and medical uses of existing drugs, hormones, other endogenous human biologicals and combinations thereof. Pantarhei adheres to the highest scientific standards for preclinical and clinical drug development.
The current pipeline of Pantarhei includes (i) Androgen Restored Contraception (ARC), adding dehydroepiandrosterone (DHEA) to oral contraceptives, (ii) the fetal estrogen Estetrol (E4) for the (co)-treatment of breast and prostate cancer and (iii) the use of the Zona Pellucida 3 (ZP3) antigen and biomarker for immunotherapy of ZP3 expressing tumors such as ovarian and prostate cancer.
For more information please visit www.pantarheibio.com or www.pantarheioncology.nl
Besins Healthcare is a privately held, global pharmaceutical company headquarter in Monaco. We are a world leader in novel therapies for gynecology and andrology. We have discovered ground-breaking technologies to improve patient well-being throughout our history. We developed several hormone therapies over the years including bioavailable natural progesterone by different routes of administration for pregnant women from conception until delivery and a natural testosterone transdermal gel for testosterone deficiency syndrome. We continue to be a leader in Estradiol Replacement Therapy with the first transdermal gel marketed in Europe. Our products are trusted and prescribed by healthcare professionals in more than 100 countries throughout the world.
For more information about Besins please visit www.besinshealthcare.co.uk
For more information about Besins please visit www.besinshealthcare.co.uk
Kitazato Corporation is a global company based in Japan, dedicated to the assisted reproductive technologies field.
World leaders in vitrification of human specimens thanks to the development and worldwide implementation of The Cryotop® Method, used by over 2,500,000 professionals a year, we perform extensive research, develop, manufacture and market medical devices and media to support a wide range of fertility treatments on the IVF LifeCycle, from IUI to PGT, including catheters, needles, oils and media.
Our work over the last decades have led Kitazato to become the undisputed market leader in cryopreservation of human gametes.
For more information about Kitazato, please visit www.kitazato-ivf.com or email: contact@kitazato.co.jp
World leaders in vitrification of human specimens thanks to the development and worldwide implementation of The Cryotop® Method, used by over 2,500,000 professionals a year, we perform extensive research, develop, manufacture and market medical devices and media to support a wide range of fertility treatments on the IVF LifeCycle, from IUI to PGT, including catheters, needles, oils and media.
Our work over the last decades have led Kitazato to become the undisputed market leader in cryopreservation of human gametes.
For more information about Kitazato, please visit www.kitazato-ivf.com or email: contact@kitazato.co.jp
Italfarmaco is a private Italian multinational company located in Milan, operating in Italy and abroad in both the pharmaceutical and fine chemical industries through its controlled and/or participated companies. Italfarmaco was established in 1938.
Today Italfarmaco Group markets ethical products in Italy, Switzerland, France, Spain, Germany, Portugal, Greece, Russia, Turkey, Chile, Peru, Morocco and also for its subsidiary company Chemi Spa in USA and Brazil, where it employs over 3000 people. Its products, always with high therapeutic content, are mainly oriented towards the cardiovascular, immuno-oncologic, gynecological, osteoporosis and neurologic area.
For more information about Italfarmaco, please visit www.italfarmaco.com/en-us/
Today Italfarmaco Group markets ethical products in Italy, Switzerland, France, Spain, Germany, Portugal, Greece, Russia, Turkey, Chile, Peru, Morocco and also for its subsidiary company Chemi Spa in USA and Brazil, where it employs over 3000 people. Its products, always with high therapeutic content, are mainly oriented towards the cardiovascular, immuno-oncologic, gynecological, osteoporosis and neurologic area.
For more information about Italfarmaco, please visit www.italfarmaco.com/en-us/